World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
19857
World Ranking
17699
National Ranking
8835

Norman Latov publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Norman Latov sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 301 publications — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Norman Latov D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Norman Latov sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 79 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Norman Latov is affiliated with Cornell University in the United States. Their research primarily spans the fields of Medicine and Neuroscience, with significant contributions to subfields including Neurology, Cellular and Molecular Neuroscience, Radiology, Nuclear Medicine and Imaging, Physiology, and Pharmacology.

The main topics of their research include:

  • Peripheral Neuropathies and Disorders
  • Hereditary Neurological Disorders
  • Myasthenia Gravis and Thymoma
  • Monoclonal and Polyclonal Antibodies Research
  • Nerve injury and regeneration
  • Pain Mechanisms and Treatments
  • Pharmacological Effects of Natural Compounds

Norman Latov's frequent coauthors include:

  • Thomas H. Brannagan
  • Angelica C. Cornejo
  • Vera Bril
  • Robert D. M. Hadden
  • Michal Bar

Research by Norman Latov has been published in several scientific journals, with multiple papers appearing in the following venues:

  • Microorganisms
  • Journal of the Peripheral Nervous System
  • Current Opinion in Neurology
  • Expert Review of Neurotherapeutics
  • Arquivos de Neuro-Psiquiatria

Selected recent publications by Norman Latov include:

  • Antibody testing in neuropathy associated with anti-Myelin-Associated Glycoprotein antibodies: where we are after 40 years, 2021, Current Opinion in Neurology
  • Campylobacter jejuni Infection, Anti-Ganglioside Antibodies, and Neuropathy, 2022, Microorganisms
  • Anti-MAG neuropathy: historical aspects, clinical-pathological correlations, and considerations for future therapeutical trials, 2024, Arquivos de Neuro-Psiquiatria

Other related works relevant to the field, although not authored by Latov, include:

  • Hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE-CIDP 1 randomized controlled trial, 2023, Journal of the Peripheral Nervous System
  • Intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): mechanisms of action and clinical and genetic considerations, 2022, Expert Review of Neurotherapeutics

Norman Latov's body of research covers various aspects of neuropathies, antibody testing approaches, and the molecular underpinnings of neurological disorders. Their focus on conditions such as chronic inflammatory demyelinating polyradiculoneuropathy, anti-Myelin-Associated Glycoprotein neuropathy, and immune-mediated neuropathies is evident in both their research topics and published works.

Best Publications

  • Distal symmetric polyneuropathy: A definition for clinical research Report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation

    J. D. England;G. S. Gronseth;G. Franklin;R. G. Miller

  • Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial

    Richard A C Hughes;Peter Donofrio;Vera Bril;Marinos C Dalakas

  • Fibrillary astrocytes proliferate in response to brain injury: A study combining immunoperoxidase technique for glial fibrillary acidic protein and radioautography of tritiated thymidine

    Norman Latov;Gajanan Nilaver;Earl A. Zimmerman;William G. Johnson

  • Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings.

    Gorazd Rosoklija;Glen Toomayan;Steven P. Ellis;John Keilp

  • Myelin-Associated Glycoprotein Is the Antigen for a Monoclonal IgM in Polyneuropathy

    Peter E. Braun;Donald E. Frail;Norman Latov

  • Practice Parameter: Evaluation of distal symmetric polyneuropathy: Role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review) Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation

    J. D. England;J. D. England;G. S. Gronseth;G. Franklin;G. T. Carter

  • Characterization of sulfated glucuronic acid containing glycolipids reacting with IgM M-proteins in patients with neuropathy.

    T Ariga;T Kohriyama;L Freddo;N Latov

  • Plasma-cell dyscrasia and peripheral neuropathy with a monoclonal antibody to peripheral-nerve myelin.

    Norman Latov;William H. Sherman;Raffaello Nemni;Giuliana Galassi

  • Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti‐MAG IgM M‐protein

    Arthur P. Hays;Norman Latov;Masami Takatsu;William H. Sherman

  • Practice Parameter: Evaluation of distal symmetric polyneuropathy: Role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation

    JD England;JD England;GS Gronseth;G Franklin;GT Carter

  • The spectrum of neurologic disease associated with anti‐GM1 antibodies

    S. A. Sadiq;F. P. Thomas;K. Kilidireas;S. Protopsaltis

  • Gangliosides GM1 and GD1b are antigens for IgM M-protein in a patient with motor neuron disease.

    L Freddo;R K Yu;N Latov;P D Donofrio

  • Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

    Ivo N van Schaik;Vera Bril;Nan van Geloven;Hans-Peter Hartung

  • Experimental conduction block induced by serum from a patient with anti‐GM1 antibodies

    Maria Santoro;Antonino Uncini;Massimo Corbo;Susan M. Staugaitis

  • Practice Parameter: The Evaluation of Distal Symmetric Polyneuropathy: The Role of Autonomic Testing, Nerve Biopsy, and Skin Biopsy (An Evidence-Based Review): Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation

    J.D. England;G.S. Gronseth;G. Franklin;G.T. Carter

  • Monoclonal IgM with unique specificity to gangliosides GM1 and GD1b and to lacto‐N ‐tetraose associated with human motor neuron disease

    N. Latov;A. P. Hays;P. D. Donofrio;J. Liao H. Ito

  • Peripheral neuropathy and anti-MAG antibodies.

    N Latov;A P Hays;W H Sherman

  • Plasma cell dyscrasia and peripheral neuropathy: identification of the myelin antigens that react with human paraproteins.

    Norman Latov;Peter E. Braun;Robin B. Gross;William H. Sherman

  • Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies

    Norman Latov

  • Peripheral neuropathy in patients with inflammatory bowel disease.

    F. A. A. Gondim;T. H. Brannagan;H. W. Sander;R. L. Chin

Frequent Co-Authors

Arthur P. Hays
Arthur P. Hays Columbia University
Lewis P. Rowland
Lewis P. Rowland Columbia University Medical Center
Marinos C. Dalakas
Marinos C. Dalakas Thomas Jefferson University
Robert K. Yu
Robert K. Yu Augusta University
Hans-Peter Hartung
Hans-Peter Hartung Heinrich Heine University Düsseldorf
Gorazd Rosoklija
Gorazd Rosoklija Columbia University
Richard A. C. Hughes
Richard A. C. Hughes University College London
Michael E. Shy
Michael E. Shy University of Iowa
Giuseppe Lauria
Giuseppe Lauria University of Milan
Robert G. Miller
Robert G. Miller California Pacific Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in healthcare, a variety of online programs make it possible to accelerate your medical career. Current nurses can explore the shortest msn to dnp program options, allowing them to advance quickly to top nursing leadership roles. Many dnp programs are now offered fully online, providing flexibility to balance education with work experience.

Entry into nursing can also be streamlined with fastest lpn program formats. These fast-track options allow aspiring nurses to move from the classroom to clinical practice sooner. For those focused on mental health, there are specialized pathways such as the fastest psych np program, which prepares graduates to become psychiatric nurse practitioners at an accelerated pace.

With these online pathways, you can find programs that match your schedule, career interests, and educational goals. Whether advancing or starting your journey in healthcare, online degrees offer more accessible ways to rise in a fast-growing field.

Best Scientists Citing Norman Latov

Trending Scientists